Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab

NCT00737763 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped drug withdrawn from market

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: efalizumab
DRUG: placebo

Sponsor

Emory University

Collaborators

[object Object]
[object Object]